Literature DB >> 11139933

Suppression of sodium current by arachidonic acid in atrial myocytes from patients with coronary heart disease.

G L Ding1, D Hu, X Liu, J Li, H Zhang, C Li.   

Abstract

This study was designed to examine the effects of arachidonic acid (AA) on atrial myocytes from patients with coronary heart disease. The patch clamp technique was used to record sodium current in human atrial myocytes, before and after administration of intracellular AA. The suppression of sodium current induced by AA was voltage- and dose-dependent, with an IC50 of 10.3 microM. The activation curves of relative conductance in absence versus presence of AA, 10 microM, nearly overlapped. The 50% channel activation was at 40.8 +/- 2.7 mV in the control state versus 42.5 +/- 3.1 mV in presence of AA (n = 10, P > 0.05). AA at 10 microM shifted the steady-state inactivation relationship significantly, from 94.5 +/- 3.4 mV to 116.6 +/- 4.1 mV (n = 11, P < 0.01) at the 50% channel inactivation point. The 50% recovery time from the inactivation state was significantly longer in the presence of 10 microM AA (27.3 +/- 1.7 ms), than in the control state (5.9 +/- 0.4 ms n = 8, P < 0.01). In conclusion, AA suppressed the sodium current and prolonged the duration of recovery from inactivation in atrial myocytes from patients with coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11139933     DOI: 10.1111/j.1540-8159.2000.tb07028.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

1.  Putative binding sites for arachidonic acid on the human cardiac Kv 1.5 channel.

Authors:  Jia-Yu Bai; Wei-Guang Ding; Akiko Kojima; Tomoyoshi Seto; Hiroshi Matsuura
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

Review 2.  Actions and Mechanisms of Polyunsaturated Fatty Acids on Voltage-Gated Ion Channels.

Authors:  Fredrik Elinder; Sara I Liin
Journal:  Front Physiol       Date:  2017-02-06       Impact factor: 4.566

3.  Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation.

Authors:  Xuewen Wang; Guangping Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Jan-Mar       Impact factor: 1.636

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.